BlackRock, Inc. 13D and 13G filings for CLOVIS ONCOLOGY INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | CLOVIS ONCOLOGY INC CLVSQ | BlackRock, Inc. BLK | 4,755,365 3.300% | -4,995,912 (-51.23%) | Filing |
| 2022-03-11 2:13 pm Unchanged | 2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | BlackRock, Inc. BLK | 9,751,277 7.500% | 0 (Unchanged) | Filing |
| 2022-02-08 5:05 pm Purchase | 2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | BlackRock, Inc. BLK | 9,751,277 7.500% | 2,890,045 (+42.12%) | Filing |